A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate

about

A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate

Item

http://www.wikidata.org/entity/Q42240905

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Patient with MSUD: Acute Man ...... oate and Sodium Phenylbutyrate

@en

A Patient with MSUD: Acute Man ...... oate and Sodium Phenylbutyrate

@nl

type

Item

label

A Patient with MSUD: Acute Man ...... oate and Sodium Phenylbutyrate

@en

A Patient with MSUD: Acute Man ...... oate and Sodium Phenylbutyrate

@nl

prefLabel

A Patient with MSUD: Acute Man ...... oate and Sodium Phenylbutyrate

@en

A Patient with MSUD: Acute Man ...... oate and Sodium Phenylbutyrate

@nl

P1476

A Patient with MSUD: Acute Man ...... oate and Sodium Phenylbutyrate

@en

P2093

Ebru Canda

http://www.w3.org/2001/XMLSchema#string

Mahmut Çoker

http://www.w3.org/2001/XMLSchema#string

Mehtap Kagnici

http://www.w3.org/2001/XMLSchema#string

Sema Kalkan Uçar

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain α-ketoacid dehydrogenase kinase.

Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.

Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.

Phenylbutyrate therapy for maple syrup urine disease.

Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease.

Lessons from genetic disorders of branched-chain amino acid metabolism.

Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects.

Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.

P304

1045031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2017/1045031

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Melis Köse

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28589054

http://www.w3.org/2001/XMLSchema#string

P932

5447276

http://www.w3.org/2001/XMLSchema#string